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Highlights 
 In striatum and cortex of R6/2 mice, mitochondrial cristae morphology was abnormal 
 Levels of the fission and fusion factors, and mitofilin protein assemblies, were unaffected 
 OPA1 oligomerisation was decreased in striatum and cortex of transgenic mice  
 Mutant huntingtin may impair OPA1 oligomerisation and cristae integrity  
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Abstract 
There is evidence of an imbalance of mitochondrial fission and fusion in patients with Huntington’s 
disease (HD) and HD animal models. Fission and fusion are important for mitochondrial homeostasis 
including mitochondrial DNA (mtDNA) maintenance and may be relevant for the selective striatal 
mtDNA depletion that we observed in the R6/2 fragment HD mouse model. We aimed to investigate 
the fission/fusion balance and the integrity of the mitochondrial membrane system in cortex and 
striatum of end-stage R6/2 mice and wild-type animals. Mitochondrial morphology was determined 
using electron microscopy, and transcript and protein levels of factors that play a key role in fission 
and fusion, including DRP1, mitofusin 1 and 2, mitofilin and OPA1, and cytochrome c and caspase 3 
were assessed by RT-qPCR and immunoblotting. OPA1 oligomerisation and mitofilin protein 
associations were evaluated using blue native gels.  In striatum and cortex of R6/2 mice, 
mitochondrial cristae morphology was abnormal. Although the overall levels of the fission and fusion 
factors were unaffected, OPA1 oligomerisation was decreased in striatum and cortex of R6/2 mice. 
Mitochondrial and cytoplasmic cytochrome c levels were similar R6/2 and wild-type mic without a 
significant increase of activated caspase 3. Our results indicate that the integrity of the mitochondrial 
cristae is compromised in striatum and cortex of the R6/2 mice and that this is most likely caused by 
impaired OPA1 oligomerisation. 
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Introduction 
Huntington`s disease (HD) is a fatal neurodegenerative disease, caused by a CAG repeat expansion 
mutation in exon 1 of the huntingtin gene (HTT) (The Huntington's Disease Collaborative Research 
Group 1993). HD is characterised by a mixed movement disorder, dementia and behavioural 
problems (Ross and Tabrizi 2011, Ross et al. 2014). While there is good evidence to suggest 
mitochondrial involvement in HD patients and genetic HD animal models (Bossy-Wetzel et al., 2008; 
Browne, 2008; Oliveira, 2010; Quintanilla and Johnson, 2009; Reddy et al., 2009), it remains less clear 
which role mitochondria actually play in the pathogenesis of HD. In addition to mitochondrial 
involvement in the pathogenesis of HD, we have shown in wild-type mice that the striatum and 
cortex exhibit inherent differences in potentially important aspects of mitochondrial biology and that 
these differences may contribute to the increased vulnerability of the striatum to the pathogenic 
events in HD (Hering et al. 2015).  
Much interest was focused recently on the fission/fusion balance in HD. Mutant huntingtin (mHTT) 
was shown to interact with the main driver of mitochondrial fission, the GTPase dynamin related 
protein 1 (DRP1), with increased DRP1 activity associated with increased fragmentation of the 
mitochondrial network in human HD fibroblast and lymphoblast  cell cultures as well as in HD mouse 
primary neurons and brain (Jin et al. 2013, Shirendeb et al. 2012, Song et al. 2011). In HD patient 
lymphoblasts and primary striatal neurons derived from YAC128 transgenic mice, DRP1 translocation 
to mitochondria was associated with increased mitochondrial fragmentation (Costa 2010). In post-
mortem HD patient striatum, mitochondria were smaller with an increase in DRP1 protein levels 
predominantly in late stage HD (Kim et al. 2010) and an increase in enzymatic DRP1 activity 
(Shirendeb et al. 2012). In HeLa cells expressing mHTT as well as in different HD cells lines, the 
mitochondrial network was shown to be more fragmented and contain mitochondria with alterations 
in cristae structure and enhanced apoptosis (Costa 2010, Costa and Scorrano 2012). Further support 
for a role of increased mitochondrial fission in the pathogenesis of HD comes from the observation 
that inhibition of DRP1 reverses the  phenotype of mitochondrial fragmentation and improves 
survival in HD mice (Guo et al. 2013).  
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Mitochondrial fission and fusion contribute to the maintenance of mitochondrial homeostasis that is 
essential for mitochondrial function, such as ATP production via oxidative phosporylation, 
mitochondrial DNA (mtDNA) stability, cellular stress responses, mitophagy and apoptosis regulation 
(Bereiter-Hahn and Voth 1994, Chan 2006a, 2006b, Twing 2008, Westermann 2010, Youle and van 
der Bliek 2012). Mitochondrial fission is necessary during cell division and, particular in neurons, for 
mitochondrial trafficking along the axon to the synapse (Lin and Sheng 2015). The translocation of 
DRP1 from the cytosol to mitochondria initiates the fission process. The mitochondrial fusion process 
can be separated into fusion of the outer mitochondrial membrane involving mitofusin 1 (MFN1) and 
mitofusin 2 (MFN2) and fusion of the inner mitochondrial membrane involving optic atrophy protein 
1 (OPA1) (reviewed in (Westermann 2010)). In addition, several proteins, including mitofilin, 
maintain the integrity of the inner mitochondrial membrane system (MINOS) (von der Malsburg et al. 
2011, Zerbes et al. 2012a, Zerbes et al. 2012b). 
In a previous study we reported lower mtDNA copy number in striatum of end-stage R6/2 mice 
without evidence of impaired mitochondrial respiratory chain activity, biogenesis or respiratory chain 
assembly (Hering et al. 2015). Given the important role of fission and fusion in the maintenance of 
mtDNA and the evidence implicating an imbalance of fission and fusion in various HD models and HD 
patient brains, we investigated the fission/fusion balance and the integrity of the mitochondrial 
membrane systems in striatum and cortex of the R6/2 HD fragment mouse model. We hypothesised 
that striatum and cortex would show an ultra-structural phenotype of increased fission (smaller, 
fragmented mitochondria) together with an increase in the amount of DRP1 protein associated with 
mitochondria of transgenic mice, indicating a shift of the fission/fusion balance towards fission.  
 
Material and Methods 
Animals 
For all experiments R6/2 transgenic mice (B6CBATg(HDexon1)62Gpb/1J) and their corresponding 
wild-type B6CBAF1/J were purchased from Jackson Laboratory. Genotyping and the CAG repeat 
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length determination (approximately 160 ± 10) were performed on DNA extracted from tail biopsies 
(Mangiarini et al. 1996). According to local regulation and EU Directive 2010/63/EU, 12 week old 
animals were sacrificed by cervical dislocation. Both striata as well as whole cortex, including all 
layers, were prepared and immediately snap frozen in liquid nitrogen and then stored at -80°C. For 
electron microscopy mice were perfused twice with PBS, followed by 4 % paraformaldehyde fixation. 
 
Electron microscopy 
Directly after fixation small pieces of about 2x2x2 mm3 from the central portion of the striatum, or 
from the middle of the cerebral cortex were carefully prepared and immediately fixed in 2.5 % 
glutaraldehyde. Two ultra-thin sections from different areas were used for electron microscopy. 
Representative images of both ultra-thin sections per sample were taken with a Jeol 1400 
Transmission Electron Microscope (JEOL GmBH). For quantification, five representative images per 
sample at x12,000 magnification were used. Images were transferred to a tablet-PC (iPad2, Apple) 
and mitochondria were outlined using the Glow Draw application (The Othernet, LLC © Daniel Cota), 
followed by quantification using ImageJ software (ImageJ 1.46r, Wayne Rasband, National Institutes 
of Health, USA). The median of individual results from each of the five images was calculated for 
mitochondrial area, number, altered cristae structure and total mitochondrial area per image. Data 
acquisition and all analyses were done blinded to the genotype of the animal. 
 
Quantitative Real-Time-PCR 
RNA was isolated using the RNeasyPlus Mini Kit (Qiagen, Germany) followed by 2 µg cDNA synthesis 
with the iSkriptTMcDNA Synthesis Kit (Bio-Rad Laboratories, Germany). For the quantitative PCR 
reactions, striatum and cortex cDNA and water as negative control were tested in triplicates in a 96 
well plate. The PCR reaction was performed using SYBR® green supermix (Bio-Rad Laboratories) and 
primer pairs against the following genes of interest: Mfn1 (mitofusin1), Mfn2 (mitofusin2), Drp1 
(dynamin 1-like protein), Opa1 (optic atrophy 1), Immt (inner membrane protein, mitochondrial), 
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Cycs (cytochrome c) (for primer sequences see Table 1). Poldip3 (polymerase (DNA-directed), delta 
interacting protein 3) and Metap1 (methionylaminopeptidase 1) were used as reference genes, 
which had homogenous stable cDNA levels (Mean CV 0.1626 and Mean M Value 0.4761) according to 
(Hellemans et al. 2007). All reactions were performed with the CFX384 Touch Real-Time PCR 
Detection Systems (Bio-Rad Laboratories) with the following programme: 95°C for 3 min, followed by 
40 cycles of 95°C for 15 sec and a primer-dependent annealing/extension temperature (see Table 1) 
for 15 sec, and finally a 60-95°C melting curve at increments of 1°C every 5 sec. 
 
Protein extraction, gel electrophoresis and western blot 
For western blots of native and denatured proteins, total lysates were prepared from striatum or 
cortex in homogenisation buffer containing 320 mM sucrose, 1 mM K+ EDTA, 10 mM Tris/HCl, pH 7.4 
and protease inhibitors (1 µg/ml of pepstatin, 1 µg/ml of leupeptin and 1 mM PMSF) and 
homogenised with Tissue Lyser for 2 min at 50 Hz followed by centrifugation at 600×g for 10 min at 
4°C. For the subcellular fractionation of mitochondria and cytoplasm, the striatum (striata pooled 
from four mice) or the cortex were homogenised on ice in 200 µl homogenisation buffer (see above) 
with a douncer homogeniser. Lysates were centrifuged at 1300 g for 10 min at 4°C. Supernatant was 
collected and stored on ice, while the pellet was re-suspended in 200 µl homogenisation buffer, 
followed by centrifugation as before. Collected supernatant was centrifuged at 17.000 x g for 15 min 
at 4 °C. The supernatant represents the cytoplasmic fraction and the pellet contains the enriched 
mitochondrial fraction and was re-suspended in 30 µl homogenisation buffer.  Total lysates were 
snap frozen and thawed three times to break mitochondrial membranes. 
For SDS-PAGE and western blot 12 % or 9 % Bis-Tris-gels were used. For protein level analysis 15 µg 
of total protein extract and for purity analyses of the subcellular fractionations 5 µg protein lysate 
were used. For analyses of the subcellular fractions 2.5 µg of mitochondria and 15 µg of the 
cytoplasmic fraction were loaded onto a gel. Native protein analyses were performed with 10 µg 
total lysate (Schagger and von Jagow 1991). After electrophoresis gels were blotted on PVDF 
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membranes (Immobilon-P, pore size 0.45 µm, Millipore) followed by total protein stain 
determination using Pierce Reversible Protein Stain Kit for PVDF Membranes (Pierce, Rockford, USA). 
Membranes were blocked in 10% non-fat milkpowder solution for 1 h, followed by primary antibody 
incubation overnight (anti-caspase 3, 9665 Cell Signaling, 1:1000; anti-cytochrome c,  BD 556433, 
1:1000; anti-DRP1, BD 611112, 1:1000; anti-mitofilin, ab93323 Abcam, 1:1000; anti-mitofusin1, 
ab126575 Abcam, 1:500; anti-mitofusin2, ab50838 Abcam, 1:1000; anti-OPA1, BD 612606, 1:1000; 
anti-NDUFA9, ab14713 Abcam, 1:1000; anti-HPRT ab109021 Abcam 1:10000). Following three 
washing steps with PBS-T (PBS with 0.3 % Tween), membranes were incubated with secondary 
antibody  (goat anti-mouse IgG (H+L)-HPR (1:3000, Bio-Rad) or goat anti-rabbit IgG (H+L) (1:10,000, 
111-035-003, Jackson ImmunoResearch)) for 1 h. All antibodies were diluted with 10% milk-PBS-T 
solution. Following three washing steps with PBS-T we used Image Quant LAS4000 according to the 
manufacturer’s instructions (GE Healthcare Life Science, Freiburg) for specific protein detection. 
Densitometry results were quantified using Image Quant software and calculated relative to total 
protein stain, which also allows the direct comparison between striatum and cortex samples. For 
total protein determination densitometry was performed for each lane loaded with 12.5 μg of 
protein using Image Quant software. From the mean grey values of immunoblot signals the 
background signal intensity was subtracted resulting in a single value for each lane. The Complex I 
subunit NDUFA9 was used as mitochondrial marker protein in mitochondrial fractions and HPRT was 
used as cytoplasmic marker in cytoplasmic fractions.  
 
Data analysis and statistics 
All experiments and data analyses were conducted blinded to the animals’ genotype. After decoding 
data were examined for normal distribution using the Kolmogorov-Smirnov test. Skewed data with 
non-normal distribution were multiplied by a factor of 10 or 100 to obtain values of more than 1, 
which is necessary for the log transformation of the data sets leading to normal distribution (Altman 
1991). 
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Normally distributed data were analysed using univariate analysis of variance (ANOVA F-test) with 
the result of the experiment as dependent variable and ‘region’ and ‘genotype’ as independent 
variables. A main effect of ‘region’ indicated differences between striatum and cortex, while a main 
effect of ‘genotype’ indicated a difference between wild-type and transgenic mice and an interaction 
of region-genotype differences in the regional patterns between wild-type and transgenic animals. 
Post-hoc analysis were performed with statistical significant level set to p=0.05 with Bonferroni 
correction for multiple pairwise comparisons. The comparison of two data sets was performed by 
using Student’s t-test. For non-normally distributed skewed data sets we used the Kruskal-Wallis-Test 
followed by Dunn`s Multiple Comparison test. All statistical analysis was performed with GraphPad 
Prism 5.  
 
Results 
Mitochondrial morphology  
Using electron microscopy we determined mitochondrial morphology, including mitochondrial size, 
number, total mitochondria area and cristae structure in striatum and cortex of 10 transgenic and 10 
wild-type mice. Mitochondrial size and number per image as well as the average mitochondrial area 
per image was similar in R6/2 and wild-type tissues (Figure 1A-D); however, we noticed a marked 
increase of mitochondria with disorganised cristae. The mitochondria contained fewer cristae, and 
the cristae were arranged in a non-parallel manner. In addition, some mitochondria appeared to 
harbour vacuoles.  We quantified the number of mitochondria with altered cristae structure and 
calculated the ratio of abnormal mitochondria to the total number of mitochondria. In striatum and 
cortex of R6/2 mice the overall proportion of mitochondria with altered cristae structure was 
increased significantly compared to wild-type tissues (Figure 1A and E, main effect of genotype, F1.36 
= 6.909, p = 0.0125). The difference in abnormal mitochondria was particularly pronounced in the 
striatum of transgenic mice (17.93 % ± 3.39 SEM versus 6.8 % ± 2.06 SEM in controls, p < 0.05; Figure 
1D).  
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Mitochondrial fission/fusion balance   
Alterations in the mitochondrial cristae structure could be caused by changes in the mitochondrial 
fission/fusion balance (Anand et al. 2014, Kushnareva et al. 2013). In R6/2 mice striatum and cortex, 
mRNA levels of the main fission driver Drp1 were lower compared to wild-type tissues (main effect of 
genotype, F1.36 = 5.05, p = 0.0309; Figure 2A). This effect was mainly produced by the lower amount 
of Drp1 in cortex of transgenic mice (t-test p<0.001). At the protein level the amount of DRP1 was 
also reduced in cortex of the transgenic mice compared to wild-type (interaction genotype*brain 
region, F1.39 = 5.04, p = 0.0305; Figure 2B, D). Mitochondrial fission is mainly initiated by the 
recruitment of cytosolic DRP1 to the outer mitochondrial membrane (Otera et al. 2013). Despite the 
lower DRP1 levels in total lysate in cortex of transgenic mice, the amount of recruited DRP1 in 
mitochondrial fractions was similar in cortex and striatal samples of transgenic and wild-type mice 
(Figure 2 C, D).   
We next assessed the mitochondrial outer membrane fusion factors MFN1 and MFN2. At the mRNA 
level, the amount of Mfn1 (main effect of brain region, F1.38 = 35.95, p < 0.001; Figure 2E) and Mfn2 
(main effect of brain region, F1.37 = 16.84, p = 0.002; Figure 2F) were lower in wild-type cortex than 
in striatum. At the protein level, MFN2 (main effect of brain region, F1.38 = 8.41, p = 0.0062; Figure 2 
H and I) was also lower in wild-type cortex compared to striatum. In transgenic mice only the mRNA 
levels of Mfn1 in striatum were higher compared to wild-type (interaction genotype*brain region, 
F1.38 = 7.93, p = 0.0077; transgenic versus wild-type striatum p < 0.01; Figure 2E).  
 
Cristae structure proteins 
We next examined factors that contribute to the control and maintenance of the mitochondrial 
cristae structure. First, we assessed mitofilin, an important member of the mitochondrial inner 
membrane organising system (MINOS) (Zerbes et al. 2012a). Mitofilin mRNA (Immt) levels, and levels 
of both the denatured mitofilin (IMMT) and native mitofilin protein assemblies were similar in wild-
type striatum and cortex as well as in transgenic and wild-type mice (Figure 3A, B, C, D).  
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Fusion of the mitochondrial inner membrane is mainly regulated by OPA1. In addition, OPA1 is also 
crucial for cristae stability. Opa1 mRNA levels in wild-type cortex were lower than in the striatum 
(main effect of brain region, F1.38 = 34.54, p < 0.0001; Figure 4A), and lower in transgenic mice than 
in wild-type (main effect of genotype, F1.38 = 7.73, p = 0.008; Figure 4A). The pattern of Opa1 mRNA 
levels differed between transgenic and wild-type mice (interaction genotype*brain region, F1.38 = 
7.73, p = 0.008). In cortex of transgenic mice the amount of Opa1 mRNA was lower than in wild-type, 
while in striatum the amount of Opa1 mRNA was similar in wild-type and transgenic mice (transgenic 
versus wild-type cortex p < 0.001; Figure 4A).  
The OPA1 precursor protein can be separated into the long membrane anchored isoform and the 
short cleaved soluble isoform. Both isoforms are present in healthy mitochondria and are necessary 
for efficient fusion (Anand et al. 2014). In wild-type and transgenic mice, the protein levels of the 
long OPA1 isoform relative to the short isoform were lower in cortex compared to striatum (main 
effect of brain region, F1.32 = 16.26, p = 0.0003; Figure 4B, C). In the cortex of transgenic mice OPA1 
levels of the short (main effect of genotype, F1.35 = 5.12, p = 0.03, transgenic versus wild-type cortex 
p < 0.05; Figure 4C, Figure S1A) and long isoforms (transgenic versus wild-type cortex p < 0.05; Figure 
4C, Figure S1B) were lower than in wild-type, with a lower ratio of long relative to short isoform 
(interaction genotype*brain region, F1.32 = 4.58, p = 0.0401, transgenic versus wild-type cortex 
posttest p < 0.05 ; Figure 4B, C). In addition to the cleavage of OPA1 during e.g. mitophagy and 
apoptosis, decreased OPA1 oligomerisation can lead to opening of cristae junctions during apoptosis 
(Frezza et al. 2006; Yamaguchi et al. 2008). OPA1 oligomer determination using blue native gel 
electrophoreses and western blot revealed three discernible bands at about 1200, 500 and 300 kDa 
(Figure 4F). In transgenic mice the amount of the high molecular weight oligomers at 1200 kDa was 
slightly reduced (Figure 4D, F), while the amount of the lowest molecular weight at 300 kDa was 
increased (main effect of genotype, F1.34 = 5.71, p = 0.0225, Figure 4E, F). The difference was 
particularly prominent in the striatum (transgenic versus wild-type striatum p < 0.05; Figure 4E, F).  
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Cytochrome c and caspase 3 
The ultra-structural abnormalities of cristae morphology and the lower amount of low molecular 
weight OPA1 oligomers in our mice could be associated with impaired mitochondrial membrane 
integrity (Frezza et al. 2006). Downregulation of OPA1 can lead to vacuolar cristae (Olichon et al. 
2003) and wider cristae structure (Frezza et al. 2006), which has been shown to be associated with 
apoptosis. A link between impaired cristae structure and apoptosis could be the release of 
cytochrome c from mitochondria into the cytoplasm. We therefore next asked if there was a shift 
from mitochondrial to cytosolic cytochrome c indicative of the release of cytochrome c from 
mitochondria into the cytosol. The total amount of cytochrome c, at mRNA level (main effect of brain 
region, F1.32 = 11.15, p = 0.0021; Figures S2A) and protein level (main effect of brain region, F1.33 = 
35.18, p < 0.0001; Figures S2B) was lower in wild-type cortex than striatum. The amount of 
cytochrome c was determined in mitochondria and the corresponding cytosol after tissue 
fractionation (Figure 5A). Levels of cytochrome c in mitochondria and cytosol were similar in 
transgenic and wild-type mice (Figure 5B). Release of cytochrome c from mitochondria into the 
cytosol could trigger cleavage of caspase 3 and subsequent induction of apoptosis. Levels of the 
cleaved active caspase 3 were slightly higher in transgenic mice (main effect of genotype, F1.25 = 
3.33, p=0.08; Figure S2C,F), even though the difference did not quite reach statistical significance. 
This is consistent with the ratios of cleaved to uncleaved caspase 3, which were similar in transgenic 
and wild-type mice (Figure S2D). 
 
Discussion 
In this study we show that in the striatum and cortex of the R6/2 HD fragment mouse model 
mitochondrial cristae morphology was abnormal. This was associated with a normal fission/fusion 
balance. However, there was less OPA1 oligomerisation. These steady state differences suggest that 
the integrity of mitochondrial cristae is compromised. However, this was not associated with leakage 
of cytochrome c into the cytosol nor substantial activation of caspase 3. 
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In our HD fragment mouse model we observed in late stage transgenic animals a higher percentage 
of cortical and striatal mitochondria with abnormal cristae than in wild-type mice. This agrees with 
findings in brain biopsies from HD patients, the 3-NP HD rat model, the quinolinic acid treated rat 
model and HD primary human lymphoblasts, where abnormal mitochondrial cristae structure has 
been described (Costa 2010, Goebel et al. 1978, Mehrotra et al. 2015, Mormone et al. 2006, Tellet-
Nagel 1974). The disruption of the mitochondrial cristae structure could be the result of impaired 
maintenance of mitochondrial outer and/or inner membrane integrity in which mitochondrial fission 
and fusion plays an important role (Archer 2014, Wai and Langer 2016). However, mitochondrial size 
and number were similar in transgenic and wild-type mice, indicating that there was no overt 
phenotype of increased fission – that would have been associated with smaller mitochondria – or 
increased fusion – that would have caused elongated mitochondria. The analyses of DRP1 and the 
mitofusins, the main drivers of fission and fusion, did reveal a lower amount of DRP1 transcripts in 
cortex and striatum, and higher mitofusin 1 mRNA in striatum of transgenic mice compared to wild-
type. While this was associated, at the protein level, with less DRP1 in transgenic cortex total lysate, 
the amount of DRP1 recruited to mitochondria was similar in transgenic and wild-type mice. 
Mitochondrial fission is mainly initiated by the recruitment of the cytosolic DRP1 to the outer 
mitochondrial membrane (Otera et al. 2013). Therefore, despite some differences in total lysate 
DRP1 in transgenic animals, the similar levels of DRP1 in mitochondria does suggest that there is no 
increase in fission at least not in late stage transgenic animals. This is consistent with the ultra-
structural mitochondrial phenotype data in that we did not find any evidence with our two-
dimensional morphological assessments to indicate a disruption in the fission/fusion balance. This 
differs from studies showing an interaction of mHTT with DRP1 that was reported to increase its 
activity resulting in increased fragmentation of the mitochondrial network in HD patient fibroblast 
and myoblast cell cultures (Song et al. 2011), and in HD patient lymphoblasts and primary striatal 
neurons derived from YAC128 transgenic mice in which DRP1 translocation to mitochondria was 
associated with increased mitochondrial fragmentation (Costa 2010). In post-mortem HD patient 
striatum, mitochondria were smaller with an increase in DRP1 protein levels predominantly in late 
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stage HD (Kim et al. 2010) and an increase in enzymatic DRP1 activity (Shirendeb et al. 2012). It is 
possible that in dividing cells such as lymphoblasts the demands on fission and fusion are higher so 
that the effects of mutant huntingtin are greater than in the steady state of our R6/2 post-mitotic 
striatal and cortical tissues. Therefore, the effects of mHTT on the fission/fusion balance may depend 
on cell type and stage of differentiation which may explain why we did not see any fission/fusion 
abnormalities in late-stage R6/2 striatum and cortex. Since the inhibition of DRP1 was shown to 
reverse a phenotype of mitochondrial fragmentation and improved survival in HD mice suggesting it 
is worth exploring DRP1 inhibition as a potential treatment in HD (Guo et al. 2013).  
Since we had no evidence of a disturbed fission/fusion balance in transgenic mice we subsequently 
investigated two proteins that are important for the integrity of the inner mitochondrial membrane 
system. Similar levels of mitofilin at the transcriptome and protein level suggest that mitofilin, an 
important member of the mitochondrial inner membrane organising system (MINOS) (von der 
Malsburg et al. 2011, Zerbes et al. 2012a, Zerbes et al. 2012b) may not be a major contributor to the 
abnormal cristae structure that we observed in transgenic mice. We then turned to OPA1 as the main 
mitochondrial inner membrane fusion factor. OPA1 plays an important role in cristae remodelling 
and mitophagy (Ramonet et al. 2013, Sekine and Ichijo 2015, Varanita et al. 2015). The cortex of wild-
type mice had less OPA1 mRNA than the striatum. The difference at the transcriptome level was not 
associated with a difference at the overall OPA1 protein level. However, the protein levels of the long 
OPA1 isoform relative to the short isoform were lower in cortex compared to striatum. In agreement 
with other data this argues for potentially higher levels of mitophagy in cortex than striatum 
(Diedrich et al. 2011), and it is possible that the cortex has an inherently higher turnover of 
mitochondrial proteins than the striatum. 
In transgenic mice OPA1 transcript levels were lower in both cortex and striatum but, in contrast to 
wild-type mice, this was associated with differences at the protein level. In the cortex of transgenic 
mice levels of both the short and the long OPA1 isoforms were lower than in wild-type. Nonetheless, 
the ratio of the long relative to the short isoform was reduced indicating more cleavage of OPA1 
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(Head et al. 2009). Our data therefore suggest that in the R6/2 mice mutant huntingtin reduces OPA1 
gene expression and promotes OPA1 cleavage. Since in transgenic striatum OPA1 isoforms were 
similar to wild-type this seems to be specific for the cortex of mutant mice. It is possible that the 
inherently higher mitophagy rate in cortex either increases the cortex’s vulnerability to the effects of 
mutant huntingtin, or is better able to compensate for those effects because it can maintain 
mitochondrial protein homeostasis better than the striatum. In both cortex and striatum there was a 
shift of OPA1 oligomers from long to short oligomers. This suggests that in our model the mutant N-
terminal huntingtin fragment affects OPA1 oligomerisation independent of OPA1 processing in the 
context of mitophagy. OPA1 oligomerisation is important for maintaining the integrity of 
mitochondrial cristae (Frezza et al. 2006, Olichon et al. 2003) and, therefore, abnormal OPA1 
oligomerisation in our transgenic mice may contribute to the abnormal cristae structure that we 
observed on EM.  
We next asked if these structural abnormalities affected the cristae’s ability to maintain the 
compartmentalisation of cytochrome c. Reduced OPA1 expression or changes in the OPA1 oligomer 
composition can affect cristae structure and integrity such that more cytochrome c is released into 
the cytosol where it can induce apoptosis (Cipolat et al. 2006, Frezza et al. 2006, Olichon et al. 2003). 
We found similar levels of mitochondrial relative to cytoplasmic cytochrome c in cortex and striatum 
of our transgenic mice. This does not agree with previous reports in the R6/2 fragment model 
(Kiechle et al, 2002) which suggested that, indeed, the abnormal cristae morphology and reduced 
OPA1 oligomerisation that we observed may affect the containment of cytochrome c within 
mitochondria with subsequent increases in cytosolic cytochrome c levels. Levels of the active form of 
caspase 3, an important executioner in apoptosis (Fernandes-Alnemri et al. 1994, Nicholson et al. 
1995) were increased in transgenic mice. However, the effect was small in accord with the notion 
that cytochrome c released into the cytosol had only a subtle, if any, effect on the cleavage and 
therefore activation of caspase 3 and was therefore probably below the threshold for the induction 
of massive apoptosis. Previous studies have shown that a cytochrome c release below 15% had no 
effect on the cleavage of caspase 3 (Khodjakov et al. 2004, Scorrano et al. 2002). In addition, 
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fragmentation of the mitochondrial network may be necessary for the complete release of 
cytochrome c into the cytosol (Scorrano et al. 2002, Yamaguchi et al. 2008). In our transgenic mice 
there was no evidence to indicate a disruption of the fission/fusion balance at the phenotypic or 
protein level even though a three-dimensional assessment of mitochondrial shape could reveal more 
subtle differences. Our data are therefore consistent with the low levels of apoptosis reported in this 
model (Dodds et al. 2014, Turmaine et al. 2000, Zhang et al. 2003). In the 3-NP HD model, higher 
levels of apoptosis have been reported in conjunction with mitochondrial cristae remodeling and 
increased cytosolic cytochrome c (Mehrotra et al. 2015), and in HD patient lymphoblasts and primary 
striatal neurons derived from YAC128 transgenic mice OPA1 oligomer disruption and increased 
sensitivity to apoptosis inducing toxins was another feature (Costa 2010). However, in HD patient 
caudate nucleus levels of apoptosis and caspase 3, while higher than in controls, were low (Vis et al. 
2005). It is possible that the low steady state levels of caspase 3 activation we observed in our 
transgenic mice may be enhanced sufficiently to cause apoptotic cell death in individual brain cells 
when mitochondria are stressed. Low levels of cell loss could then accumulate over time. It is also 
possible that caspase 3 has additional roles in HD such as cleavage of huntingtin (D'Amelio et al. 
2012). 
Taken together, in cortex and striatum of the late stage HD R6/2 fragment model we observed a 
phenotype of ultra-structurally abnormal mitochondrial cristae associated with reduced OPA1 
oligomerisation. This did not affect the compartmentalisation of cytochrome c consistent with the 
non-significant low levels of caspase 3 cleavage. This is in good agreement with the low levels of 
apoptosis that have been reported in this model. Mitochondrial cristae remodelling and cytochrome 
c release seem a common feature across different HD models including human cell models (Costa 
and Scorrano 2012, Goebel et al. 1978, Kiechle et al. 2002, Mehrotra et al. 2015, Mormone et al. 
2006, Tellet-Nagel 1974). While we do not find evidence for an imbalance of fission and fusion at 
steady state it is possible that with increased mitochondrial stress mutant huntingtin may promote 
fission (Jin et al. 2013, Ventura et al. 2012) and further destabilise mitochondrial cristae to promote 
cytochrome c release sufficient to cause apoptosis. However, it is also possible that there is a fission-
17 
 
independent mechanism by which mutant huntingtin affects mitochondrial cristae modelling via 
OPA1 oligomerisation (Cipolat et al. 2006, Frezza et al. 2006, Olichon et al. 2003).    
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Figures 
Figure 1. Ultrastructural mitochondrial morphology. A. Transgenic mice (tg) harboured more 
mitochondria with vacuoles than wild-type (wt). Mitochondria of the cortex showed less cristae in 
transgenic mice compared to wild-type (magnification x40,000; arrow=mitochondria). B-D. Semi-
quantitative analysis of ultrastructural mitochondrial morphology. Average area per mitochondrion 
(B), number of mitochondria (C), and mitochondrial area per image (D) were similar in wild-type and 
transgenic mice. E. The percentage of mitochondria with altered cristae morphology was significantly 
higher in transgenic mice than wild-type. Data are means and SEM from n=10 animals. Uni-variate 
analysis of variance (ANOVA F-test), * p < 0.05, # p < 0.05 main effect of genotype.  
Figure 2. Fission and fusion factors. A. mRNA levels (RT-qPCR) of Drp1 were lower in striatum and 
cortex of transgenic mice (tg) compared to wild-type (wt). B, D. On western blot with corresponding 
quantification relative to protein stain, DRP1 protein levels were lower in cortex of transgenic mice. 
C, D. Protein levels of DRP1 in enriched mitochondrial fractions relative to the total amount of DRP1 
were similar in transgenic and wild-type. E, F. mRNA levels (RT-qPCR) of Mfn1 (E) and Mfn2 (F) were 
lower in wild-type cortex compared to striatum. Mfn1 levels in transgenic striatum were higher than 
in wild-type. G-I. Representative western blot with corresponding quantification relative to protein 
stain showed reduced MFN2 protein levels in cortex compared to striatum, while MFN1 was similar 
in both brain regions. DRP1 protein data are log transformed. Data are means (±SEM) from n=8-10 
samples. Uni-variate analysis of variance (ANOVA F-test), * p < 0.05, *** p < 0.001, # p < 0.05 main 
effect of genotype. 
Figure 3. The inner mitochondrial membrane protein mitofilin. A. mRNA levels (RT-qPCR) of 
mitofilin (Immt) were similar in transgenic striatum and cortex compared to wild-type. B, C. 
Quantitative western blot analysis of SDS-PAG relative to total protein stain showed that mitofilin 
(IMMT) levels were similar in cortex and striatum of wild-type and transgenic mice. D. Blue native gel 
electrophoresis followed by western blot analysis of mitofilin protein associations revealed no 
19 
 
differences between wild-type and transgenic tissues. Data are means (±SEM) from n=8-10 animals. 
Uni-variate analysis of variance (ANOVA F-test) 
 
Figure 4. The inner mitochondrial membrane protein OPA1. A. Lower Opa1 mRNA levels (qPCR) in 
cortex compared to striatum. Cortex of transgenic mice had less Opa1 mRNA compared to wild-type. 
B, C. At protein level (western blot) the ratio of the long relative to the short OPA1 isoform was lower 
in cortex compared to striatum. In cortex of transgenic mice, the long to short OPA1 isoform ratio 
was lower compared to wild-type cortex.  D, E, F. Blue native gel electrophoresis and western blot 
analysis of OPA1 oligomers relative to total protein stain showed an increase of small oligomers of 
~300 kDa in striatum of transgenic mice. Data are means (±SEM) from n=8-10 animals. Uni-variate 
analysis of variance (ANOVA F-test), * p < 0.05, *** p < 0.00; # p < 0.05, ## p < 0.01 main effect of 
genotype. 
Figure 5. Cytochrome c A. Fractionation leads to a mitochondrial fraction (MF) and a cytosolic 
fraction (CF). Compared to total lysate (TL) the MF is strongly enriched for mitochondria, while 
mitochondria are strongly diminished in the CF. B. In separate western blots cytosolic, or 
mitochondrial, fractions from transgenic (tg) and wild-type (wt) mice contain similar amounts of 
cytochrome c. HPRT is the loading control for the cytosol, NDUFA9 for mitochondria.  
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Table1: Primer sequences for qPCR 
Name RefSeq Primer sequence Efficiency Temperature     (°C)  
Mfn1 NM_024200.4 GCCCTGTCCAGGTGCATAAT 107.5 64.4  
TGGCCGAAGATTGCAGTGAT    
Mfn2 NM_133201.2 GGTCAGGGGTATCAGCGAAG 107.7 64.4  
TTGTCCCAGAGCATGGCATT    
Drp1 NM_152816.2 CCCGGAGACCTCTCATTCTG 95.1 62  
GTCTTGAGTTTTTCCATGTGGC     
Opa1 NM_001199177.1 CAGTTTAGCTCCCGACCTGG 106.9 60  
ACAAGAGAAGGGCCTCAGAAA    
Immt NM_029673.3 TCAAAAAGGTCCAGGCTGCT 105.8 60  
CCCTTTCCATCCAGGAGTGAT    
Cycs NM_007808.4 AACGTTCGTGGTGTTGACC 120.8 60  
TTATGCTTGCCTCCCTTTTC    
Poldip3  NM_178627.3 AGGTAGGCTGTGTTTGTCGG 101.5 61.4  
CCAATACGTTCCTGCACCCT    
Metap1  NM_175224.4 TGCGACTCGTGTGTAGGC 102.4 60  
CTTCAGTAGTTACACCCGCTTTAAT    
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Supplementary material: 
Figure S1. Quantitative OPA1 protein levels. At protein level (western blot) transgenic mice contain 
less of the short (A) and long (B) isoform of OPA1 relative to total OPA1 in cortex. C. Quantitative 
western blot analysis relative to total protein stain showed similar levels of OPA1 oligomers of 480 
kDa in striatum and cortex of transgenic mice compared to wild-type. Data are means (±SEM) from 
n=8-10 animals. Uni-variate analysis of variance (ANOVA F-test), * p < 0.05. 
Figure S2. Cytochrome c and Caspase 3. A. mRNA levels (RT-qPCR) of cytochrome c were lower in 
cortex than in striatum. B. At protein level (quantitative western blot) total lysate cytochrome c was 
lower in cortex than striatum. C. At the protein level (western blot) the amount of uncleaved caspase 
3 was similar in wild-type and transgenic mice. D. Similar levels of caspase 3 cleaved relative to the 
uncleaved isoform in wild-type and transgenic mice. Data are means (±SEM) from n=8-10 animals. 
Uni-variate analysis of variance (ANOVA F-test). 
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